Loading the company…
Loading the company…
㈜와이엔케이바이오코스
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Gyeonggi, founded in 2017. Industry: Bio & Pharma. Revenue for 2025 was ₩20.9bn. It has 36 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2024-07-01 · newest first
본 발명은 상처 치유, 여드름 치유 등에 사용되는 하이드로콜로이드 패치에 관한 것으로, 폴리우레탄으로 이루어지는 기재층과, 상기 기재층의 일면에 형성되는 하이드로콜로이드 드레싱과, 상기 기재층의 일면에 상기 하이드로콜로이드 드레싱을 덮도록 부착되는 이형층을 포함하며, 상기 하이드로콜로이드 드레싱은, 살리실산, 셀룰로오스검, 폴리이소부틸렌 및 티트리오일과, 레조르시놀, 아젤라산 및 징크피리치온 중 적어도 하나 이상이 함유되어 구성되는 활성제를 포함하고, 상기 하이드로콜로이드 드레싱은, 나이아신아마이드, 알란토인 및 히알루론산 중 적어도 하나를 포함한다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 17.1 | 20.9 |
| Cost of sales | 7.2 | 9.6 |
| Gross profit (loss) | 9.9 | 11.3 |
| Selling, general and administrative expenses | 2.1 | 2.7 |
| Operating income (loss) | 7.8 | 8.6 |
| Non-operating income | 10.5 | 5.5 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.3 | 0.4 |
| Other | 10.2 | 5.1 |
| Non-operating expenses | 1.1 | 8.0 |
| Other losses | 0.1 | 0.0 |
| Finance costs | 0.1 | 0.1 |
| Other | 0.9 | 7.9 |
| Profit (loss) before tax | 17.2 | 6.1 |
| Income tax expense | 1.5 | 1.5 |
| Net income (loss) | 15.7 | 4.7 |
Revenue ₩20.9bn, up 22.3% YoY.
Operating margin 41.0% (prior 45.5%).
Net income ₩4.7bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06